Volume 19, number 1
 PDF Downloads: 322

Escherichia coli Strains in Patients with Inflammatory Bowel Diseases; A review

Hadba Al-Amrah* Hanan Alotaibi and Nemat Sadiq

Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah-21589, Saudi Arabia

Corresponding Author E-mail: hggaber@kau.edu.sa

DOI : http://dx.doi.org/10.13005/bbra/2966

ABSTRACT:

Gastrointestinal tract conditions, including inflammatory bowel diseases (IBDs) such as ulcerative colitis (UC) and Crohn’s disease, have been linked to adhesive invasive Escherichia coli (AIEC) pathotypes, with comparable pathogenic properties, although the incidence of AIEC with UC and CD is generally undetermined. While a significant advance has been made in understanding the pathogenic processes of AIEC since it was first characterized a decade ago, the molecular basis that determines the phenotypic features of AIEC pathotypes is still unknown. This article reviews studies that examine the prevalence of E. coli in patients with IBD and discusses its pathophysiological role.

KEYWORDS: Adherent Invasive Escherichia Coli; Crohn’s Disease; Epidemiology; Inflammatory Bowel Disease; Pathogenesis

Download this article as: 
Copy the following to cite this article:

Al-Amrah H, Alotaibi H, Sadiq N. Escherichia coli Strains in Patients with Inflammatory Bowel Diseases; A review. Biosci Biotech Res Asia 2022;19(1).
Copy the following to cite this URL:

Al-Amrah H, Alotaibi H, Sadiq N. Escherichia coli Strains in Patients with Inflammatory Bowel Diseases; A review. Biosci Biotech Res Asia 2022;19(1).Available from: https://bit.ly/3LeweCK

[ HTML Full Text]

Back to TOC